medigraphic.com
ISSN 2594-1518 (Digital)
ISSN 1405-0099 (Impreso)

2011, Número S1

<< Anterior Siguiente >>

Cir Gen 2011; 33 (S1)


Actualidades sobre reflujo gastroesofágico

Quijano OF

Idioma: Español
Referencias bibliográficas: 21
Paginas: 63-64
Archivo PDF: 171.87 Kb.


FRAGMENTO

Tratamiento quirúrgico de la enfermedad por reflujo astroesofágico en pacientes con obesidad mórbida

El aumento del porcentaje de individuos obesos en las últimas décadas ha sido alarmante, la prevalencia de obesidad definida como IMC › 30 se ha incrementado del 13% en 1960 al 32% en 2004. Aún más, 3% de los hombres y 7% de las mujeres americanas se clasificaron como obesidad mórbida IMC › 40 en el 2006. En México la prevalencia de obesidad infantil es la mayor del mundo y se calcula que más del 50% de la población adulta tiene sobrepeso.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Flegal KM, Carroll MD, Orden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-1727.

  2. Ogden CL, Carroll MD et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.

  3. El Serag HB, Graham DY, Satia JA et al. Obesity increases esophageal acid exposure. Gut 2007; 56: 749-755.

  4. Shahin A, Hagen JA Chan LS, De Meester SR et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg 2009; 13: 1440-1447.

  5. Herbella FA, Sweet MP, Tedesco P et al. Gastroesophageal reflux disease and obesity. pathophysiology and implications for treatment. J Gastrointest Surg 2007; 11: 286-290.

  6. Gerson LB, Ullah N, Fass R et al. Does body mass index differ between patients with Barrett’s oesophagus and patients with chronic gastro-oesophageal reflux disease? Alimen Pharmacol Ther 2007; 25: 1079-1086.

  7. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 2619-28.

  8. Hampel H, Abraham NS, El-Serag HB. Meta-Analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211.

  9. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001; 15: 986-989.

  10. Morgenthal CB, Lin E, Hunter JG et al. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long term outcome. Surg Endosc 2007; 21: 1978-1984.

  11. D’Alessio MJ, Arnaoutakis D, Giarelli RN et al. Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 2005; 9: 949-954.

  12. Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis 2009; 5: 139-143.

  13. Zainabadi K, Courcoulas AP, Awais O, Raftopoulos I. Laparoscopic revision of Nissen fundoplication to Roux-en-Y gastric bypass in morbidly obese patients. Surg Endosc 2008; 22: 2737-40.

  14. Madalosso CA, Gurski RR, Callegari-Jacques SM et al. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity. Ann Surg 2010; 251: 244-247.

  15. Rebecci F, Rocchietto S, Giaccone C, Talha A, Morino M. Gastroesophageal reflux disease and esophageal motility in morbidly obese patients submitted to laparoscopic adjustable silicone gastric banding or laparoscopic vertical banded gastroplasty. Surg Endosc 2010 Jul 30 Epub ahead of print.

  16. Prachand VN, Alverdy JC. Gastroesophageal reflux disease and severe obesity: Fundoplication or bariatric surgery? World J Gastroenterol 2010; 16: 3757-3761.

  17. Belperio JA, Weigt SS, Fishbein MC, Lynch JP, 3rd. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 2009; 6: 108-21.

  18. D’Ovidio F, Keshavjee S. Gastroesophageal reflux and lung transplantation. Dis Esophagus 2006; 19: 315-20.

  19. Hartwig MG, Appel JZ, Davis RD. Antireflux surgery in the setting of lung transplantation: strategies for treating gastro-esophageal reflux disease in a high-risk population. Thorac Surg Clin 2005; 15: 417-427.

  20. Balsara KR, Cantu E, Bush EL et al. Early fundoplication reduces the incidence of chronic allograft dysfunction in patients with gastroesophageal reflux disease. J Heart Lung Transpl 2008; 27: S125.

  21. Shah NS, Force SD, Mitchell PO et al. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts transplantation proceedings 2010; 42: 2702-2706.




2020     |     www.medigraphic.com